F S&P 500
5,212.75 -1.00 (-0.02%) F Dow Jones
39,012.00 -15.00 (-0.04%) F Nasdaq
18,204.50 +5.00 (+0.03%) E-mini Russell 2000 Index Futur
2,072.10 -4.60 (-0.22%) Petróleo
78.06 -0.32 (-0.41%) Oro
2,316.70 -7.50 (-0.32%)
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO)
Jagsonpal Pharmaceuticals Limited
T-210 J, Shahpur Jat
New Delhi 110049
India
91 12 4440 6710
https://www.jagsonpal.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 940
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Manish Gupta | MD & Director | 10.59M | N/D | 1967 |
| Mr. Abhishek Joshi | Company Secretary & Compliance Officer | 100k | N/D | N/D |
| Mr. Ashish Lakhotia | Chief Financial Officer | N/D | N/D | N/D |
| Bharat Chugh | Assistant General Manager of Human Resources | N/D | N/D | N/D |
Descripción
Jagsonpal Pharmaceuticals Limited engages in the manufacture and trading of pharmaceutical products and active pharmaceutical ingredients in the areas in the areas of women health, pain and analgesics, and general medicine in India and internationally. It offers pharmaceutical formulations and over the counter drugs in the areas of gynaecology, orthopaedics, and allergy management. It offers drugs in the form of tablets, softgels, injections, capsules, and syrups. The company was incorporated in 1978 and is headquartered in New Delhi, India.
Gestión corporativa
La calificación ISS Governance QuickScore de Jagsonpal Pharmaceuticals Limited a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
